Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, November 22, 2018 · 469,040,851 Articles · 3+ Million Readers

Accelrys To Feature Pipeline Pilot At Bio-IT Exhibition

April 17, 2010 (FinancialWire) — Accelrys, Inc. (NASDAQ: ACCL), a provider of scientific business intelligence software and services, will participate in the Bio-IT World Conference & Exhibition being held at the World Trade Center in Boston, MA from April 20-22, 2010.

Accelrys will showcase its leading scientific business intelligence platform, Accelrys Pipeline Pilot™, the Accelrys Discovery Studio modeling and simulation application, as well as its chemical and new biologics registration systems in booth #301-303.

At noon Wednesday, April 21, Accelrys will present: "Pipelining Your Next Generation Sequencing Data," by Nancy Miller Latimer, M.S., senior product manager, biological sciences & analytics, Accelrys.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate ( written by FIRST Research Consortium ( member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website ( Contact FinancialWire(tm) directly via

[frlylrf] [biomedphrm] [hlthcrdp] [infrntntchnlgy]

Powered by EIN Presswire